Is HIF-1α a good marker for tumor hypoxia?

被引：7

作者：

Begg, AC ^{[1
]}

机构：

[1] Netherlands Canc Inst, Div Expt Therapy, NL-1066 CX Amsterdam, Netherlands

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2003年 / 56卷 / 04期

关键词：

D O I：

10.1016/S0360-3016(03)00286-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：917 / 919

页数：3

共 5 条

[1] GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: Relationship to pimonidazole binding [J].

Airley, RE ;

Loncaster, J ;

Raleigh, JA ;

Harris, AL ;

Davidson, SE ;

Hunter, RD ;

West, CML ;

Stratford, IJ .

INTERNATIONAL JOURNAL OF CANCER, 2003, 104 (01) :85-91

[2] HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors [J].

Janssen, HLK ;

Haustermans, KMG ;

Sprong, D ;

Blommestijn, G ;

Hofland, I ;

Hoebers, FJ ;

Blijweert, E ;

Raleigh, JA ;

Semenza, GL ;

Varia, MA ;

Balm, AJ ;

van Velthuysen, MLF ;

Delaere, P ;

Sciot, R ;

Begg, AC .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (05) :1537-1549

[3] Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch [J].

Lando, D ;

Peet, DJ ;

Whelan, DA ;

Gorman, JJ ;

Whitelaw, ML .

SCIENCE, 2002, 295 (5556) :858-861

[4]

Raleigh JA, 2000, CLIN CANCER RES, V6, P855

[5] Signal transduction to hypoxia-inducible factor 1 [J].

Semenza, GL .

BIOCHEMICAL PHARMACOLOGY, 2002, 64 (5-6) :993-998

← 1 →